FilingReader Intelligence
Luye Pharma converts $25m convertible bonds into shares
August 14, 2025 at 10:20 AM UTC•By FilingReader AI
Luye Pharma Group converted $25m of its 5.85% convertible bonds due 2025 into 52.9 million new ordinary shares at HK$3.672 per share.
The new shares represent 1.4% of the company's issued share capital before conversion. Outstanding convertible bonds fell from $90m to $65m, while total issued shares increased to 3.84 billion.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
HKEX:2186•Hong Kong Exchange
News Alerts
Get instant email alerts when Luye Pharma Group publishes news
Free account required • Unsubscribe anytime